logo for AlphaVax

AlphaVax

Business Services · North Carolina, United States · 62 Employees

View Company Info for Free

About

Headquarters

2 Triangle Dr, Durham, North Carolina, 27709, U...

Phone Number

(919) 595-0400

Revenue

$14 Million

Industry

Business Services General Business Services

Recent News & Media

No recent news or media

Highlights

$31.9M

Total Funding Amount

$12.7M

Most Recent Funding Amount

4

Number of Funding Rounds

Who is AlphaVax

Based in Research Triangle Park, NC, AVX has developed a new generation of vaccine products for diseases that represent significant market opportun ities based on its novel, proprietary vector platform technology. AlphaVax is at the forefront of a completely new class of potent biopharmaceutical products aimed to participate in this market with its viral vector technology that has the clear potential to redefine the traditional concept of vaccines. The AlphaVax proprietary viral vector gene expression system has the potential for developing a range of effective vaccines in both cancer and infectious disease. AlphaVax is focusing the commercial potential of its alphavaccine system in cancer immunotherapy. The development of immunotherapeutic treatments for cancer is a rapidly growing area in which AlphaVax will be taking a lead position in developing new treatment modalities utilizing its proprietary technology.Read more

AlphaVax's Social MediaPopular SearchesAlphavax IncAlphavaxAlphavax Human Vaccines IncAlphavax Human VaccinesAlphavax Human Vaccines - IncSIC Code 28,283NAICS Code 32,325Show more

AlphaVax Org Chart

PhoneEmail
Andrew Graham

Vice President, Development & Technical Opera...

PhoneEmail

PhoneEmail

PhoneEmail

Is AlphaVax your ideal costumer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Similar Companies to AlphaVax

See more similar companies
Illustration of an envelope

AlphaVax Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateFeb 04, 2007
RoundSeries E
Amount$12.7M
Investors
Funding DateJan 13, 2004
RoundSeries D
Amount-
Investors
Funding DateJul 23, 2000
RoundSeries C
Amount$11M
Investors
See More

$31.9M

Total Funding Amount

$12.7M

Most Recent Funding Amount

4

Number of Funding Rounds

AlphaVax Tech Stack

A closer look at the technologies used by AlphaVax

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Frequently Asked Questions regarding AlphaVax

Where is AlphaVax located?
AlphaVax's headquarters are located at 2 Triangle Dr, Durham, North Carolina, 27709, United States
What is AlphaVax's phone number?
AlphaVax's phone number is (919) 595-0400
What is AlphaVax's official website?
AlphaVax's official website is www.alphavax.com
What is AlphaVax's Revenue?
AlphaVax's revenue is $14 Million
What is AlphaVax's SIC code?
AlphaVax's SIC: 28,283
What is AlphaVax's NAICS code?
AlphaVax's NAICS: 32,325
How many employees does AlphaVax have?
AlphaVax has 62 employees
What industry does AlphaVax belong to?
AlphaVax is in the industry of: Business Services General, Business Services
What is AlphaVax competition?
AlphaVax top competitors include: TheraVectys, HOOKIPA Pharma, Celldex Therapeutics, Intercell
What technology does AlphaVax use?
Some of the popular technologies that AlphaVax uses are: Google AdSense, DoubleClick, Mapbox GL JS API, Google Maps API
How do I contact AlphaVax?
AlphaVax contact info: Phone number: (919) 595-0400 Website: www.alphavax.com
What does AlphaVax do?

Based in Research Triangle Park, NC, AVX has developed a new generation of vaccine products for diseases that represent significant market opportunities based on its novel, proprietary vector platform technology. AlphaVax is at the forefront of a completely new class of potent biopharmaceutical products aimed to participate in this market with its... viral vector technology that has the clear potential to redefine the traditional concept of vaccines. The AlphaVax proprietary viral vector gene expression system has the potential for developing a range of effective vaccines in both cancer and infectious disease. AlphaVax is focusing the commercial potential of its alphavaccine system in cancer immunotherapy. The development of immunotherapeutic treatments for cancer is a rapidly growing area in which AlphaVax will be taking a lead position in developing new treatment modalities utilizing its proprietary technology.Read More

What are AlphaVax social media links?
AlphaVax Linkedin page AlphaVax Twitter page
How much funding has AlphaVax raised to date?
AlphaVax has raised $31.9 Million in 4 funding rounds
When was the last funding round for AlphaVax?
AlphaVax closed its last funding round on Feb 04, 2007 with the amount of $12.7 Million
Is AlphaVax a public company?
AlphaVax is private company therefore does not currently have an official ticker symbol
See more information about AlphaVax

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.